BioLargo Technologies Inc. and Blood Systems Announce Strategic Marketing Agreement.Business Editors and Health/Medical Writers RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--Aug. 1, 2001 BioLargo Technologies Inc., a subsidiary of BioCurex Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BOCX), announced today the signing of a three-year definitive product purchase and marketing agreement with Blood Systems, one of the nation's oldest and largest non-profit community blood providers. Blood Systems, based in Scottsdale, Arizona, is the parent organization of BioCARE, Blood Systems Laboratories and United Blood Services, with 70 regional blood centers and community donor centers serving patients in 18 states. "Blood Systems has been seeking a blood absorbent product for nine years that would meet its product validation testing standards and the BioLargo i2Absorb, with biocidal bi·o·cid·al adj. Of or relating to an agent that is destructive to living organisms. biocidal (bī´ōsī´d iodine in a super absorbent material, is the only product we've found that meets our performance criteria," said Michael Lamb, Vice President Planning and Development of Blood Systems. i2 ABSORB starts as a simple mixture of chemicals contained in an absorbent material and deploys disinfectant iodine alongside super absorbent and fluff-pulp fibers used in the air-laid non-woven manufacturing industry. The product would be used with blood shipments to absorb, contain and decontaminate de·con·tam·i·nate tr.v. de·con·tam·i·nat·ed, de·con·tam·i·nat·ing, de·con·tam·i·nates 1. To eliminate contamination in. 2. any spill. "Nearly every business segment within the $40 billion non-woven industry can adapt this technology to their products," said Floyd Wandler, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of BioLargo." We are particularly pleased to have Blood Systems take a leadership role in using the product in the transport of blood specimens within North America. Their vision and expertise in blood services will showcase our products and provide a level of excellence. Our technology is extremely versatile and can be easily converted or customized for multiple uses. This enables the user to efficiently produce a final product without costly delays or additional investment." There are approximately 25 million blood products distributed for transfusion each year. The transport of hazardous materials/potentially infectious substances is regulated by the Department of Transportation. Based upon the terms of the marketing agreement, BioCARE, a division of Blood Systems, is named the sole-source provider of the BioLargo absorbent pad and its related packaging for the transport of blood products in the United States and Canada. The product will be formally introduced at the American Association of Blood Banks 54th Annual Meeting and Transfusion Medicine transfusion medicine Blood banking A subspecialty of clinical pathology or internal medicine which is involved in Pt management through administration of blood cells and blood products including fresh-frozen plasma and cryoprecipitate; TM specialists are versant in Expo October 13th - 17th, 2001 at the Henry B. Gonzalez Convention Center The Henry B. Gonzalez Convention Center is located in downtown San Antonio along the banks of the San Antonio River Walk. The facility is the central component of the city’s successful convention industry. The center, named for the late US congressman Henry B. in San Antonio, Texas “San Antonio” redirects here. For other uses, see San Antonio (disambiguation). San Antonio is the second most populous city in Texas, the third most populous metropolitan area in Texas, and is the seventh most populous city in the United States. As of the 2006 U.S. . BioLargo Technologies, Inc: BioLargo Technologies Inc., headquartered in Rancho Santa Margarita, California Not to be confused with Santa Margarita, California, a community in San Luis Obispo County. Rancho Santa Margarita is a city in Orange County, California, United States. It is a newer, planned community set upon rolling hills. , has patented technologies that deliver unique value to packaging and disposable absorbent products used in a variety of applications. BioLargo products make Institutional Universal Precautions universal precautions, n.pl 1. approaches to infection control designed to prevent transmission of bloodborne diseases, such as AIDS and hepatitis B in health care settings. safety features available for the general population. BioCurex Technologies (OTCBB:BOCX - news): is a biotechnology company that has developed patented/proprietary technology in the areas of cancer diagnosis, tumor imaging and therapeutics. The technology identifies a common cancer biomarker or receptor known as RECAF, thereby allowing detection of malignant cancers from blood tests or tissue biopsies. Forward-looking statements contained in this news release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any such statements are subject to risks and uncertainties that could cause actual results of events to differ materially from those anticipated in such forward looking statements. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion